Davis R M Inc. Lowers Holdings in AMETEK, Inc. (NYSE:AME)

Davis R M Inc. trimmed its holdings in AMETEK, Inc. (NYSE:AME) by 1.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 450,048 shares of the technology company’s stock after selling 6,526 shares during the period. AMETEK makes up about 1.5% of Davis R M Inc.’s holdings, making the stock its 27th largest holding. Davis R M Inc.’s holdings in AMETEK were worth $41,323,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of AME. Park Avenue Securities LLC lifted its stake in AMETEK by 1.5% during the third quarter. Park Avenue Securities LLC now owns 8,125 shares of the technology company’s stock worth $746,000 after purchasing an additional 124 shares in the last quarter. 180 Wealth Advisors LLC lifted its stake in AMETEK by 4.1% during the second quarter. 180 Wealth Advisors LLC now owns 3,411 shares of the technology company’s stock worth $301,000 after purchasing an additional 134 shares in the last quarter. CENTRAL TRUST Co lifted its stake in AMETEK by 4.6% during the second quarter. CENTRAL TRUST Co now owns 3,103 shares of the technology company’s stock worth $278,000 after purchasing an additional 137 shares in the last quarter. Berman Capital Advisors LLC lifted its stake in AMETEK by 51.3% during the second quarter. Berman Capital Advisors LLC now owns 454 shares of the technology company’s stock worth $41,000 after purchasing an additional 154 shares in the last quarter. Finally, Diversified Trust Co lifted its stake in AMETEK by 4.3% during the second quarter. Diversified Trust Co now owns 4,200 shares of the technology company’s stock worth $382,000 after purchasing an additional 175 shares in the last quarter. Institutional investors own 86.15% of the company’s stock.

In other news, Director Elizebeth R. Varet sold 4,000 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $85.69, for a total value of $342,760.00. Following the sale, the director now directly owns 95,670 shares in the company, valued at $8,197,962.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.80% of the stock is currently owned by company insiders.

Shares of NYSE AME opened at $88.98 on Friday. The stock has a market cap of $20.32 billion, a P/E ratio of 27.09, a PEG ratio of 2.06 and a beta of 1.21. The company has a current ratio of 2.17, a quick ratio of 1.53 and a debt-to-equity ratio of 0.51. AMETEK, Inc. has a 12-month low of $63.14 and a 12-month high of $92.86. The business’s fifty day simple moving average is $89.04 and its 200-day simple moving average is $87.24.

AMETEK (NYSE:AME) last announced its quarterly earnings data on Tuesday, July 30th. The technology company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.02. The business had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.32 billion. AMETEK had a return on equity of 19.27% and a net margin of 16.32%. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm earned $0.83 earnings per share. On average, equities analysts forecast that AMETEK, Inc. will post 4.1 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.63%. The ex-dividend date was Friday, September 13th. AMETEK’s payout ratio is currently 17.02%.

A number of research analysts have commented on AME shares. Bank of America cut AMETEK from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $105.00 to $95.00 in a research note on Friday, October 11th. Morgan Stanley upped their price target on AMETEK from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 31st. ValuEngine cut AMETEK from a “hold” rating to a “sell” rating in a research note on Thursday. Oppenheimer upped their price target on AMETEK from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 31st. Finally, Royal Bank of Canada set a $95.00 price objective on AMETEK and gave the company a “buy” rating in a research note on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, one has given a hold rating and thirteen have assigned a buy rating to the company’s stock. AMETEK currently has a consensus rating of “Buy” and an average target price of $94.42.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Recommended Story: Discount Rate

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.